A subsequent assay of proteins from pancreatic cancer tissue samples (Fig. 1I) and cell samples (Fig. 1J) once again corroborated the effect of IGF2BP3 on TGF-β/Smads pathway activation. The gene discussed is TGFB1; the disease is pancreatic neoplasm.